Literature DB >> 21438069

Budget allocation and the revealed social rate of time preference for health.

Mike Paulden1, Karl Claxton.   

Abstract

Appropriate decisions based on cost-effectiveness evaluations of health-care technologies depend upon the cost-effectiveness threshold and its rate of growth as well as some social rate of time preference for health. A more traditional approach to this problem is outlined before a social decision-making approach is developed, which demonstrates that social time preference for health is revealed through the budget allocations made by a socially legitimate higher authority. The relationship between the social time preference rate for health, the growth rate of the cost-effectiveness threshold and the rate at which the higher authority can borrow or invest is then examined. We establish that the social time preference rate for health is implied by the budget allocation and the health production functions in each period. As such, the social time preference rate for health depends not on the social time preference rate for consumption or growth in the consumption value of health but on growth in the cost-effectiveness threshold and the rate at which the higher authority can save or borrow between periods. The implications for discounting and the policies of bodies such as NICE are then discussed.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Year:  2011        PMID: 21438069     DOI: 10.1002/hec.1730

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  10 in total

1.  Some inconsistencies in NICE's consideration of social values.

Authors:  Mike Paulden; James F O'Mahony; Anthony J Culyer; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

2.  Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Mike Paulden; James F O'Mahony; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

3.  Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.

Authors:  James Lomas; Karl Claxton; Jessica Ochalek
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

4.  Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.

Authors:  James F O'Mahony; Anthony T Newall; Joost van Rosmalen
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

Review 5.  Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.

Authors:  Baudouin Standaert; Rino Rappuoli
Journal:  J Mark Access Health Policy       Date:  2017-08-31

6.  Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.

Authors:  Simon Walker; Susan Griffin; Miqdad Asaria; Aki Tsuchiya; Mark Sculpher
Journal:  Appl Health Econ Health Policy       Date:  2019-10       Impact factor: 2.561

7.  Accounting for Timing when Assessing Health-Related Policies.

Authors:  Karl Claxton; Miqdad Asaria; Collins Chansa; Julian Jamison; James Lomas; Jessica Ochalek; Mike Paulden
Journal:  J Benefit Cost Anal       Date:  2019-01-26

Review 8.  Discounting in Economic Evaluations.

Authors:  Arthur E Attema; Werner B F Brouwer; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

9.  Private and social time preference for health outcomes: A general population survey in Iran.

Authors:  Alireza Mahboub-Ahari; Abolghasem Pourreza; Ali Akbari Sari; Trevor A Sheldon; Maryam Moeeni
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

10.  Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.

Authors:  Jessica Ochalek; Kaja Abbas; Karl Claxton; Mark Jit; James Lomas
Journal:  BMJ Glob Health       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.